Pathological conditions involving extracellular hemoglobin: Molecular mechanisms, clinical significance, and novel therapeutic opportunities for α1-microglobulin

Antioxidants and Redox Signaling

Volumn 17, Issue 5, 2012, Pages 813-846

  Olsson, Magnus G ^a   Allhorn, Maria ^a   Bülow, Leif ^a   Hansson, Stefan R ^a   Ley, David ^a   Olsson, Martin L ^a   Schmidtchen, Artur ^a   Åkerström, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANTIHYPERTENSIVE AGENT; BLOOD SUBSTITUTE; FREE RADICAL; HAPTOGLOBIN; HEME; HEME OXYGENASE 1; HEME OXYGENASE 2; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; HEMOPEXIN; IRON; MAGNESIUM SULFATE; NITRIC OXIDE; OXYGEN; POLYMERIZED HEMOGLOBIN;

ANEMIA; ANTIOXIDANT ACTIVITY; BLOOD TRANSFUSION REACTION; BRAIN HEMORRHAGE; ERYTHROCYTE; HEMOLYTIC ANEMIA; HUMAN; INFLAMMATION; LEG ULCER; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTECTION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SEIZURE; WHITE MATTER INJURY;

ALPHA-GLOBULINS; HEMOGLOBINS; HUMANS;

VERTEBRATA;

EID: 84863487217     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4282     Document Type: Review

References (341)

1. Abraham NG and Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127, 2008. (Pubitemid 351439218)
2. Ackerman Z, Seidenbaum M, Loewenthal E, and Rubinow A. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol 124: 1376-1378, 1988.
3. Adams-Chapman I, Hansen NI, Stoll BJ, and Higgins R. Neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion. Pediatrics 121: e1167-e1177, 2008.
4. Aft RL and Mueller GC. Hemin-mediated DNA strand scission. J Biol Chem 258: 12069-12072, 1983.
5. Afzal-Ahmed I, Mann GE, Shennan AH, Poston L, and Naftalin RJ. Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. Free Radic Biol Med 42: 1781-1790, 2007. (Pubitemid 46754755)
6. Agren MS, Eaglstein WH, Ferguson MW, Harding KG, Moore K, Saarialho-Kere UK, and Schultz GS. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) 210: 3-17, 2000.
7. Alayash AI. Haptoglobin: old protein with new functions. Clin Chim Acta 412: 493-498, 2011.
8. Allhorn M, Berggard T, Nordberg J, Olsson ML, and Akerström B. Processing of the lipocalin a1-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99: 1894-1901, 2002. (Pubitemid 34525466)
9. Allhorn M, Klapyta A, and Akerström B. Redox properties of the lipocalin a1-microglobulin: reduction of cytochrome c, hemoglobin, and free iron. Free Radic Biol Med 38: 557-567, 2005. (Pubitemid 40416851)
10. Allhorn M, Lundqvist K, Schmidtchen A, and Akerstrom B. Heme-scavenging role of alpha1-microglobulin in chronic ulcers. J Invest Dermatol 121: 640-646, 2003. (Pubitemid 37072280)
11. Allhorn M, and Collin M. Sugar-free antibodies-the bacterial solution to autoimmunity? Ann NY Acad Sci 1173: 664-669, 2009.
12. Altruda F, Poli V, Restagno G, Argos P, Cortese R, and Silengo L. The primary structure of human hemopexin deduced from cDNA sequence: evidence for internal, repeating homology. Nucleic Acids Res 13: 3841-3859, 1985.
13. Amoresano A, Minchiotti L, Cosulich ME, Campagnoli M, Pucci P, Andolfo A, Gianazza E, and Galliano M. Structural characterization of the oligosaccharide chains of human alpha1-microglobulin from urine and amniotic fluid. Eur J Biochem 267: 2105-2112, 2000. (Pubitemid 30185298)
14. An X and Mohandas N. Disorders of red cell membrane. Br J Haematol 141: 367-375, 2008. (Pubitemid 351521152)
15. Anderson BF, Baker HM, Norris GE, Rumball SV, and Baker EN. Apolactoferrin structure demonstrates ligandinduced conformational change in transferrins. Nature 344: 784-787, 1990.
16. Anderson UD, Olsson MG, Rutardóttir S, Centlow M, Kristensen KH, Isberg PE, Thilaganathan B, Akerström B, and Hansson SR. Fetal hemoglobin and a1-microglobulin as first-and early second-trimester predictive biomarkers for preeclampsia. Am J Obstet Gynecol 204: 520 e1-520 e5, 2011.
17. Applegate LA, Luscher P, and Tyrrell RM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 51: 974-978, 1991.
18. Arner ES and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109, 2000.
19. Arnhold J. Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc) 69: 4-9, 2004.
20. Arnhold J and Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 500: 92-106, 2010.
21. Ascenzi P, Bocedi A, Visca P, Altruda F, Tolosano E, Beringhelli T, and Fasano M. Hemoglobin and heme scavenging. IUBMB Life 57: 749-759, 2005. (Pubitemid 41781830)
22. Axt-Fliedner R. Second trimester uterine artery Doppler ultrasound as a screening test for adverse pregnancy outcome. Clin Exp Obstet Gynecol 31: 9-11, 2004. (Pubitemid 38200405)
23. Azarov I, He X, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, and Kim-Shapiro DB. Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 18: 296-302, 2008.
24. Babiker-Mohamed H, Olsson ML, Boketoft A, Lögdberg L, and Akerström B. a1-microglobulin is mitogenic to human peripheral blood lymphocytes. Regulation by both enhancing and suppressive serum factors. Immunobiology 180: 221-234, 1990. (Pubitemid 20080583)
25. Babiker-Mohamed H, Akerström B, and Lögdberg L. Mitogenic effect of alpha-1-microglobulin on mouse lymphocytes. Evidence of T-and B-cell cooperation, B-cell proliferation, and a low-affinity receptor on mononuclear cells. Scand J Immunol 32: 37-44, 1990. (Pubitemid 20214588)
26. Baker HM, Anderson BF, and Baker EN. Dealing with iron: common structural principles in proteins that transport iron and heme. Proc Natl Acad Sci USA 100: 3579-3583, 2003. (Pubitemid 36418076)
27. Balla G, Jacob HS, Eaton JW, Belcher JD, and Vercellotti GM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 11: 1700-1711, 1991.
28. Baudin-Creuza V, Chauvierre C, Domingues E, Kiger L, Leclerc L, Vasseur C, Celier C, and Marden MC. Octamers and nanoparticles as hemoglobin based blood substitutes. Biochim Biophys Acta 1784: 1448-1453, 2008.
29. Berggard T, Enghild JJ, Badve S, Salafia CM, Lögdberg L, and Akerström B. Histologic distribution and biochemical properties of a1-microglobulin in human placenta. Am J Reprod Immunol 41: 52-60, 1999. (Pubitemid 29108231)
30. Berggard T, Oury TD, Thogersen IB, Akerström B, and Enghild JJ. a1-microglobulin is found both in blood and in most tissues. J Histochem Cytochem 46: 887-894, 1998.
31. Berggard T, Thelin N, Falkenberg C, Enghild JJ, and Akerström B. Prothrombin, albumin and immunoglobulin A form covalent complexes with a1-microglobulin in human plasma. Eur J Biochem 245: 676-683, 1997. (Pubitemid 27223901)
32. Bian Y, Rong Z, and Chang TM. Polyhemoglobinsuperoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substit Immobil Biotechnol 39: 127-136, 2011.
33. Boretti FS, Buehler PW, D'Agnillo F, Kluge K, Glaus T, Butt OI, Jia Y, Goede J, Pereira CP, Maggiorini M, Schoedon G, Alayash AI, and Schaer DJ. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest 119: 2271-2280, 2009.
34. Bouic P, Kanitakis J, Schmitt D, Vincent C, Revillard JP, and Thivolet J. Alpha 1-microglobulin: a new antigenic component of the epidermo-dermal junction in normal human skin. Br J Dermatol 112: 35-41, 1985. (Pubitemid 15198175)
35. Bouic P, Vincent C, and Revillard JP. Localization of alpha 1-microglobulin (HC protein) in normal human tissues: an immunohistochemical study using monoclonal antibodies. Histochem J 16: 1311-1324, 1984. (Pubitemid 15125880)
36. Braggins PE, Trakshel GM, Kutty RK, and Maines MD. Characterization of two heme oxygenase isoforms in rat spleen: comparison with the hematin-induced and constitutive isoforms of the liver. Biochem Biophys Res Commun 141: 528-533, 1986. (Pubitemid 17001894)
37. Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, Aminoff, D and Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 80: 173-195, 1998. (Pubitemid 28185056)
38. Bratt T, Cedervall T, and Akerström B. Processing and secretion of rat a1-microglobulin-bikunin expressed in eukaryotic cell lines. FEBS Lett 354: 57-61, 1994. (Pubitemid 24331705)
39. Bratt T, Olsson H, Sjöberg EM, Jergil B, and Akerström B. Cleavage of the a1-microglobulin-bikunin precursor is localized to the Golgi apparatus of rat liver cells. Biochim Biophys Acta 1157: 147-154, 1993. (Pubitemid 23171064)
40. Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med 364: 146-156, 2011.
41. Brosens JJ, Pijnenborg R, and Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies. Am J Obstet Gynecol 187: 1416-1423, 2002. (Pubitemid 35397496)
42. Broughton Pipkin F. What is the place of genetics in the pathogenesis of pre-eclampsia? Biol Neonate 76: 325-330, 1999. (Pubitemid 29520991)
43. Brouwer A, Groenendaal F, van Haastert IL, Rademaker K, Hanlo P, and de Vries L. Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for post-hemorrhagic ventricular dilatation. J Pediatr 152: 648-654, 2008.
44. Bruce LJ. Red cell membrane transport abnormalities. Curr Opin Hematol 15: 184-190, 2008. (Pubitemid 351509346)
45. Bucci E, Kwansa H, Koehler RC, and Matheson B. Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion. Artif Cells Blood Substit Immobil Biotechnol 35: 11-18, 2007. (Pubitemid 46324165)
46. Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, Jia Y, Mikolajczyk M, Boretti FS, Schoedon G, Alayash AI, and Schaer DJ. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113: 2578-2586, 2009.
47. Buehler PW and D'Agnillo F. Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives. Antioxid Redox Signal 12: 275-291, 2010.
48. Buehler PW, Vallelian F, Mikolajczyk MG, Schoedon G, Schweizer T, Alayash AI, and Schaer DJ. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. Antioxid Redox Signal 10: 1449-1462, 2008.
49. Buehler PW, Zhou Y, Cabrales P, Jia Y, Sun G, Harris DR, Tsai AG, Intaglietta M, and Palmer AF. Synthesis, biophysical properties and pharmacokinetics of ultrahigh molecular weight tense and relaxed state polymerized bovine hemoglobins. Biomaterials 31: 3723-3735, 2010.
50. Bunn H. (Ed) Hemoglobin. VCH Weinheim, 1992.
51. Bylund J, Brown KL, Movitz C, Dahlgren C, and Karlsson A. Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic Biol Med 49: 1834-1845, 2010.
52. Cabrales P, Tsai AG, and Intaglietta M. Hemorrhagic shock resuscitation with carbon monoxide saturated blood. Resuscitation 72: 306-318, 2007. (Pubitemid 46073337)
53. Caccia D, Ronda L, Frassi R, Perrella M, Del Favero E, Bruno S, Pioselli B, Abbruzzetti S, Viappiani C, and Mozzarelli A. PEGylation promotes hemoglobin tetramer dissociation. Bioconjug Chem 20: 1356-1366, 2009.
54. Calero M, Escribano J, Grubb A, and Mendez E. Location of a novel type of interpolypeptide chain linkage in the human protein HC-IgA complex (HC-IgA) and identification of a heterogeneous chromophore associated with the complex. J Biol Chem 269: 384-389, 1994. (Pubitemid 24026671)
55. Camejo G, Halberg C, Manschik-Lundin A, Hurt-Camejo E, Rosengren B, Olsson H, Hansson GI, Forsberg GB, and Ylhen B. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res 39: 755-766, 1998. (Pubitemid 28163278)
56. Centlow M, Carninci P, Nemeth K, Mezey E, Brownstein M, and Hansson SR. Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil Steril 90: 1834-1843, 2008.
57. Centlow M, Wingren C, Borrebaeck C, Brownstein MJ, and Hansson SR. Differential gene expression analysis of placentas with increased vascular resistance and pre-eclampsia using whole-genome microarrays. J Pregnancy 2011: 472354, 2011.
58. Chan P and Salier JP. Mouse alpha-1-microglobulin/bikunin precursor: cDNA analysis, gene evolution and physical assignment of the gene next to the orosomucoid locus. Biochim Biophys Acta 1174: 195-200, 1993. (Pubitemid 23250705)
59. Chang TM. Future generations of red blood cell substitutes. J Intern Med 253: 527-535, 2003. (Pubitemid 36543292)
60. Chang TM. Blood substitutes based on nanobiotechnology. Trends Biotechnol 24: 372-377, 2006. (Pubitemid 44041704)
61. Chelikani P, Fita I, and Loewen PC. Diversity of structures and properties among catalases. Cell Mol Life Sci 61: 192-208, 2004. (Pubitemid 38183572)
62. Chen JY, Scerbo M, and Kramer G. A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics (Sao Paulo) 64: 803-813, 2009.
63. Chen L, Mao SJ, and Larsen WJ. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-alpha-trypsin inhibitor family. J Biol Chem 267: 12380-12386, 1992.
64. Cimen MY. Free radical metabolism in human erythrocytes. Clin Chim Acta 390: 1-11, 2008.
65. Cole RH and Vandegriff KD. MP4, a vasodilatory PEGylated hemoglobin. Adv Exp Med Biol 701: 85-90, 2011.
66. Cooper CE. (Ed). Radical Reactions of Haem Proteins. London: BMJ Books/Intensive Care Society, 2002, pp.66-79.
67. Cooper CE, Patel RP, Brookes PS, and Darley-Usmar VM. Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends Biochem Sci 27: 489-492, 2002. (Pubitemid 35279586)
68. Davies CE, Wilson MJ, Hill KE, Stephens P, Hill CM, Harding KG, and Thomas DW. Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 9: 332-340, 2001. (Pubitemid 34038760)
69. Davies KJ. Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem 262: 9895-9901, 1987.
70. de Albuquerque Wobeto VP, Zaccariotto TR, and Sonati MF. Polymorphism of human haptoglobin and its clinical importance. Genet Mol Biol 31: 602-620, 2008.
71. de Groot CJM and Taylor RN. New Insights into the etiology of pre-eclampsia. Ann Med 25: 243-249, 1993. (Pubitemid 23209467)
72. Delanghe JR and Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 312: 13-23, 2001. (Pubitemid 32913576)
73. Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood Rev 21: 1-20, 2007. (Pubitemid 46110925)
74. DeMars DD, Katzmann JA, Kimlinger TK, Calore JD, and Tracy RP. Simultaneous measurement of total and IgAconjugated alpha-1-microglobulin by a combined immunoenzyme/immunoradiometric assay technique. Clin Chem 35: 766-772, 1989. (Pubitemid 19162068)
75. Dexlin-Melby L, Sandström A, Centlow M, Nygren S, Hansson SR, Borrebaeck CAK, and Wingren C. Tissue proteome profiling of preeclamptic placenta using recombinant antibody microarrays. Proteomics Clin Appl 4: 794-807, 2010.
76. Diarra-Mehrpour M, Bourguignon J, Sesboue R, Mattei MG, Passage E, Salier JP, and Martin JP. Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. Eur J Biochem 179: 147-154, 1989. (Pubitemid 19097669)
77. Diarra-Mehrpour M, Bourguignon J, Sesboue R, Salier JP, Leveillard T, and Martin JP. Structural analysis of the human inter-alpha-trypsin inhibitor light-chain gene. Eur J Biochem 191: 131-139, 1990. (Pubitemid 20219039)
78. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002. (Pubitemid 34654215)
79. Duley L. Pre-eclampsia, eclampsia, and hypertension. Clin Evid (Online) pii: 1402, 2011.
80. Egler RA, Fernandes E, Rothermund K, Sereika S, de Souza-Pinto N, Jaruga P, Dizdaroglu M, and Prochownik EV. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 24: 8038-8050, 2005. (Pubitemid 41746747)
81. Eisenstein RS, Garcia-Mayol D, Pettingell W, and Munro HN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA 88: 688-692, 1991. (Pubitemid 21916088)
82. Ekström B and Berggard I. Human a1-microglobulin. Purification procedure, chemical and physiochemical properties. J Biol Chem 252: 8048-8057, 1977. (Pubitemid 8243687)
83. Escribano J, Grubb A, Calero M, and Mendez E. The protein HC chromophore is linked to the cysteine residue at position 34 of the polypeptide chain by a reductionresistant bond and causes the charge heterogeneity of protein HC. J Biol Chem 266: 15758-15763, 1991. (Pubitemid 21907723)
84. Estep T, Bucci E, Farmer M, Greenburg G, Harrington J, Kim HW, Klein H, Mitchell P, Nemo G, Olsen K, Palmer A, Valeri CR, and Winslow R. Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working Group Workshop, March 1, 2006. Transfusion 48: 776-782, 2008. (Pubitemid 351430350)
85. Everse J and Hsia N. The toxicities of native and modified hemoglobins. Free Radic Biol Med 22: 1075-1099, 1997. (Pubitemid 27084145)
86. Faber HR, Groom CR, Baker HM, Morgan WT, Smith A, and Baker EN. 1.8 A crystal structure of the C-terminal domain of rabbit serum haemopexin. Structure 3: 551-559, 1995.
87. Falanga V, Kirsner R, Katz MH, Gould E, Eaglstein WH, and McFalls S. Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during ulcer healing. J Dermatol Surg Oncol 18: 409-414, 1992.
88. Falkenberg C, Enghild JJ, Thogersen IB, Salvesen G, and Akerström B. Isolation and characterization of fibronectina1-microglobulin complex in rat plasma. Biochem J 301 (Pt 3): 745-751, 1994.
89. Falkenberg C, Grubb A, and Akerström B. Isolation of rat serum a1-microglobulin. Identification of a complex with alpha 1-inhibitor-3, a rat alpha 2-macroglobulin homologue. J Biol Chem 265: 16150-16157, 1990.
90. Fernandez-Luna JL, Leyva-Cobian F, and Mollinedo F. Identification of the protein HC receptor. FEBS Lett 236: 471-474, 1988.
91. Fibach E and Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med 8: 609-619, 2008.
92. Flower DR. The lipocalin protein family: structure and function. Biochem J 318 (Pt 1): 1-14, 1996. (Pubitemid 26283618)
93. Forget BH and Higgs DR. (Eds). Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. New York: Cambridge University Press, 2009.
94. Fries E and Blom AM. Bikunin-not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 32: 125-137, 2000. (Pubitemid 30001817)
95. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet SF, and Pinsky DJ. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7: 598-604, 2001. (Pubitemid 32448328)
96. Fukai T and Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15: 1583-1606, 2011.
97. Futagi Y, Suzuki Y, Toribe Y, Nakano H, and Morimoto K. Neurodevelopmental outcome in children with posthemorrhagic hydrocephalus. Pediatr Neurol 33: 26-32, 2005. (Pubitemid 40910210)
98. Futagi Y, Toribe Y, Ogawa K, and Suzuki Y. Neurodevelopmental outcome in children with intraventricular hemorrhage. Pediatr Neurol 34: 219-224, 2006.
99. Ganfornina L, Sanchez D, Greene LH, and Flower DR. The lipocalin protein family. Protein sequence, structure and relationship to calycin superfamily. In: Lipocalins, edited by Akerström B, Borregaard N, Flower DR, and Salier JP. Georgetown, TX: Landes Bioscience, 2006, pp. 17-27.
100. Giannubilo SR, Tranquilli AL, Santolini C, Prinicipi F, Mancinelli R, and Littarru GP. Placental CoQ10 levels in HELLP syndrome. Biofactors 25: 159-163, 2005. (Pubitemid 44070844)
101. Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, Kollia P, Anagnou NP, Chui DH, Wajcman H, Hardison RC, and Patrinos GP. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat 28: 206, 2007.
102. Goldsmith LA. Clinical Snippets. J Invest Dermatol 121: V, 2003.
103. Goswami T, Rolfs A, and Hediger MA. Iron transport: emerging roles in health and disease. Biochem Cell Biol 80: 679-689, 2002. (Pubitemid 36124826)
104. Goyal MM and Basak A. Human catalase: looking for complete identity. Protein Cell 1: 888-897, 2010.
105. Gozzelino R, Jeney V, and Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354, 2010.
106. Granger JP, Alexander BT, Bennett WA, and Khalil RA. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 14: 178S-185S, 2001. (Pubitemid 32506713)
107. Graversen JH, Madsen M, and Moestrup SK. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol 34: 309-314, 2002. (Pubitemid 34164272)
108. Grey M, Yainoy S, Prachayasittikul V, and Bulow L. A superoxide dismutase-human hemoglobin fusion protein showing enhanced antioxidative properties. FEBS J 276: 6195-6203, 2009.
109. Grinberg LN, O'Brien PJ, and Hrkal Z. The effects of hemebinding proteins on the peroxidative and catalatic activities of hemin. Free Radic Biol Med 27: 214-219, 1999. (Pubitemid 29353102)
110. Grubb A, Mendez E, Fernandez-Luna JL, Lopez C, Mihaesco E, and Vaerman JP. The molecular organization of the protein HC-IgA complex (HC-IgA). J Biol Chem 261: 14313-14320, 1986. (Pubitemid 17196342)
111. Grubb AO, Lopez C, Tejler L, and Mendez E. Isolation of human complex-forming glycoprotein, heterogeneous in charge (protein HC), and its IgA complex from plasma. Physiochemical and immunochemical properties, normal plasma concentration. J Biol Chem 258: 14698-14707, 1983. (Pubitemid 14220311)
112. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 917: 219-223, 1987. (Pubitemid 17004970)
113. Halliwell B and Gutteridge JM. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 18: 125-126, 1995.
114. Halliwell B and Gutteridge JMC. Free Radicals in Biology and Medicine, 4th ed. Oxford University Press, Oxford, 2007.
115. Hanley S and Powell R. Sequence of a cDNA clone encoding the Atlantic salmon alpha 1-microglobulin/bikunin protein. Gene 147: 297-298, 1994. (Pubitemid 24306350)
116. Hansson SR, Chen Y, Brodszki J, Chen M, Hernandez-Andrade E, Inman JM, Kozhich OA, Larsson I, Marsal K, Medstrand P, Xiang CC, and Brownstein MJ. Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod 12: 169-179, 2006.
117. Hardison RC. A brief history of hemoglobins: plant, animal, protist, and bacteria. Proc Natl Acad Sci USA 93: 5675-5679, 1996. (Pubitemid 26190738)
118. Harnois T, Rousselot M, Rogniaux H, and Zal F. High-level production of recombinant Arenicola marina globin chains in Escherichia coli: a new generation of blood substitute. Artif Cells Blood Substit Immobil Biotechnol 37: 106-116, 2009.
119. Harrison GA, Humphrey KE, Jones N, Badenhop R, Guo G, Elakis G, Kaye JA, Turner RJ, Grehan M, Wilton AN, Brennecke SP, and Cooper DW. A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 60: 1158-1167, 1997. (Pubitemid 27194100)
120. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, and Noguchi M. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336: 241-250, 2004. (Pubitemid 38891741)
121. Henkel-Honke T and Oleck M. Artificial oxygen carriers: a current review. AANA J 75: 205-211, 2007. (Pubitemid 46906371)
122. Herrera E and Barbas C. Vitamin E: action, metabolism and perspectives. J Physiol Biochem 57: 43-56, 2001.
123. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989. (Pubitemid 19214215)
124. Hu D and Kluger R. Functional cross-linked hemoglobin bis-tetramers: geometry and cooperativity. Biochemistry 47: 12551-12561, 2008.
125. Hu T, Li D, Manjula BN, Brenowitz M, Prabhakaran M, and Acharya SA. PEGylation of Val-1(alpha) destabilizes the tetrameric structure of hemoglobin. Biochemistry 48: 608-616, 2009.
126. Hung TH, Skepper JN, Charnock-Jones DS, and Burton GJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90: 1274-1281, 2002. (Pubitemid 34787409)
127. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, and Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood 106: 2572-2579, 2005. (Pubitemid 41510836)
128. Ide H, Itoh H, and Nawa Y. Sequencing of cDNAs encoding alpha 1-microglobulin/bikunin of Mongolian gerbil and Syrian golden hamster in comparison with man and other species. Biochim Biophys Acta 1209: 286-292, 1994.
129. Immenschuh S and Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 7: 768-777, 2005. (Pubitemid 40563217)
130. Immenschuh S, Nell C, Iwahara S, Katz N, and Muller-Eberhard U. Gene regulation of HBP 23 by metalloporphyrins and protoporphyrin IX in liver and hepatocyte cultures. Biochem Biophys Res Commun 231: 667-670, 1997. (Pubitemid 27217574)
131. Ishii T, Iwahashi H, Sugata R, and Kido R. Oxidation of 3-hydroxykynurenine catalyzed by methemoglobin with hydrogen peroxide. Free Radic Biol Med 13: 17-20, 1992.
132. Itoh H, Tomita M, Kobayashi T, Uchino H, Maruyama H, and Nawa Y. Expression of inter-alpha-trypsin inhibitor light chain (bikunin) in human pancreas. J Biochem 120: 271-275, 1996. (Pubitemid 26335918)
133. Iwahara S, Satoh H, Song DX, Webb J, Burlingame AL, Nagae Y, and Muller-Eberhard U. Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry 34: 13398-13406, 1995.
134. Jarolim P, Lahav M, Liu SC, and Palek J. Effect of hemoglobin oxidation products on the stability of red cell membrane skeletons and the associations of skeletal proteins: correlation with a release of hemin. Blood 76: 2125-2131, 1990.
135. Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, and Sternberg P. Redox state of glutathione in human plasma. Free Radic Biol Med 28: 625-635, 2000. (Pubitemid 30136044)
136. Jose MD and Lynn KL. Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria. Clin Nephrol 56: 172-174, 2001. (Pubitemid 32707828)
137. Kalantari H and Das DK. Physiological effects of resveratrol. Biofactors 36: 401-406, 2010.
138. Kapralov A, Vlasova, II, Feng W, Maeda A, Walson K, Tyurin VA, Huang Z, Aneja RK, Carcillo J, Bayir H, and Kagan VE. Peroxidase activity of hemoglobin-haptoglobin complexes: covalent aggregation and oxidative stress in plasma and macrophages. J Biol Chem 284: 30395-30407, 2009.
139. Kastern W, Björck L, and Akerström B. Developmental and tissue-specific expression of a1-microglobulin mRNA in the rat. J Biol Chem 261: 15070-15074, 1986. (Pubitemid 17218076)
140. Kaumeyer JF, Polazzi JO, and Kotick MP. The mRNA for a proteinase inhibitor related to the HI-30 domain of interalpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC). Nucleic Acids Res 14: 7839-7850, 1986.
141. Kawahara A, Hikosaka A, Sasado T, and Hirota K. Thyroid hormone-dependent repression of a1microglobulin/bikunin precursor (AMBP) gene expression during amphibian metamorphosis. Dev Genes Evol 206: 355-362, 1997. (Pubitemid 27087033)
142. Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA, McCowan L, Roberts C, Cooper GJ, Kell DB, and Baker PN. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 56: 741-749, 2010.
143. Khwaja O and Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 93: F153-F161, 2008. (Pubitemid 352038509)
144. Kim-Shapiro DB, Schechter AN, and Gladwin MT. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 26: 697-705, 2006. (Pubitemid 43732141)
145. Kim KM, Pae HO, Zheng M, Park R, Kim YM, and Chung HT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res 101: 919-927, 2007. (Pubitemid 350287179)
146. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, and Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 409: 198-201, 2001. (Pubitemid 32144285)
147. Krohne-Ehrich G, Schirmer RH, and Untucht-Grau R. Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem 80: 65-71, 1977. (Pubitemid 8209983)
148. Kronborg C, Vittinghus E, Allen J, and Knudsen UB. Excretion patterns of large and small proteins in pre-eclamptic pregnancies. Acta Obstet Gynecol Scand 90: 897-902, 2011.
149. Kumar S and Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 157: 175-188, 2005. (Pubitemid 40726102)
150. Kutty RK and Maines MD. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem 256: 3956-3962, 1981.
151. Lambright DG, Sondek J, Bohm A, Skiba NP, Hamm HE, and Sigler PB. The 2.0 A crystal structure of a heterotrimeric G protein. Nature 379: 311-319, 1996.
152. Lara FA, Kahn SA, da Fonseca AC, Bahia CP, Pinho JP, Graca-Souza AV, Houzel JC, de Oliveira PL, Moura-Neto V, and Oliveira MF. On the fate of extracellular hemoglobin and heme in brain. J Cereb Blood Flow Metab 29: 1109-1120, 2009.
153. Larsson J, Allhorn M, and Akerström B. The lipocalin a1-microglobulin binds heme in different species. Arch Biochem Biophys 432: 196-204, 2004. (Pubitemid 39470016)
154. Larsson J, Wingardh K, Berggard T, Davies JR, Lögdberg L, Strand SE, and Akerström B. Distribution of iodine 125-labeled a1-microglobulin in rats after intravenous injection. J Lab Clin Med 137: 165-175, 2001. (Pubitemid 32203196)
155. Latunde-Dada GO, Simpson RJ, and McKie AT. Recent advances in mammalian haem transport. Trends Biochem Sci 31: 182-188, 2006. (Pubitemid 43357998)
156. Laurell CB and Nyman M. Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin. Blood 12: 493-506, 1957.
157. Leaver MJ, Wright J, and George SG. Conservation of the tandem arrangement of alpha 1-microglobulin/bikunin mRNA: cloning of a cDNA from plaice (Pleuronectes platessa). Comp Biochem Physiol Biochem Mol Biol 108: 275-281, 1994. (Pubitemid 24247794)
158. Lee JW, Kim SH, and Yoon CJ. Hemosiderin deposition on the renal cortex by mechanical hemolysis due to malfunctioning prosthetic cardiac valve: report of MR findings in two cases. J Comput Assist Tomogr 23: 445-447, 1999. (Pubitemid 29235160)
159. Lees CC, Brown AS, Harrington KF, Beacon HJ, Martin JF, and Campbell S. A cross-sectional study of platelet volume in healthy normotensive women with bilateral uterine artery notches. Ultrasound Obstet Gynecol 10: 277-281, 1997. (Pubitemid 27485326)
160. Levonen AL, Patel RP, Brookes P, Go YM, Jo H, Parthasarathy S, Anderson PG, and Darley-Usmar VM. Mechanisms of cell signaling by nitric oxide and
161. Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, Farbstein D, Pollak M, Soloveichik YZ, Strauss M, Alshiek J, Livshits A, Schwartz A, Awad H, Jad K, and Goldenstein H. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 12: 293-304, 2010.
162. Liao JC, Hein TW, Vaughn MW, Huang KT, and Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA 96: 8757-8761, 1999. (Pubitemid 29354864)
163. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, and Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 316: 1343-1347, 1998. (Pubitemid 28195872)
164. Lim SK, Kim H, bin Ali A, Lim YK, Wang Y, Chong SM, Costantini F, and Baumman H. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 92: 1870-1877, 1998. (Pubitemid 28446675)
165. Linden JV, Wagner K, Voytovich AE, and Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 40: 1207-1213, 2000.
166. Lindqvist A, Bratt T, Altieri M, Kastern W, and Akerström B. Rat a1-microglobulin: co-expression in liver with the light chain of inter-alpha-trypsin inhibitor. Biochim Biophys Acta 1130: 63-67, 1992.
167. Lindqvist A, Rouet P, Salier JP, and Akerström B. The a1-microglobulin/bikunin gene: characterization in mouse and evolution. Gene 234: 329-336, 1999. (Pubitemid 29296906)
168. Lindqvist A and Akerström B. Bovine a1-microglobulin/bikunin. Isolation and characterization of liver cDNA and urinary a1-microglobulin. Biochim Biophys Acta 1306: 98-106, 1996. (Pubitemid 26120718)
169. Lindqvist A and Akerström B. Isolation of plaice (Pleuronectes platessa) a1-microglobulin: conservation of structure and chromophore. Biochim Biophys Acta 1430: 222-233, 1999. (Pubitemid 29127218)
170. Lipstein H, Lee CC, and Crupi RS. A current concept of eclampsia. Am J Emerg Med 21: 223-226, 2003. (Pubitemid 36734688)
171. Little HN and Neilands JB. Binding of haematin by human serum albumin. Nature 188: 913-915, 1960.
172. Lloyd RV, Hanna PM, and Mason RP. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Radic Biol Med 22: 885-888, 1997. (Pubitemid 27058352)
173. Lopez C, Grubb A, and Mendez E. Human protein HC displays variability in its carboxyl-terminal amino acid sequence. FEBS Lett 144: 349-353, 1982.
174. Lubos E, Loscalzo J, and Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15: 1957-1997, 2011.
175. Lui FE and Kluger R. Enhancing nitrite reductase activity of modified hemoglobin: bis-tetramers and their PEGylated derivatives. Biochemistry 48: 11912-11919, 2009.
176. Luzzatto L, Gianfaldoni G, and Notaro R. Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol 153: 709-720, 2011.
177. Lögdberg L and Wester L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta 1482: 284-297, 2000.
178. Lögdberg L and Akerström B. Immunosuppressive properties of a1-microglobulin. Scand J Immunol 13: 383-390, 1981.
179. Lögdberg L, Akerström B, and Shevach EM. a1-microglobulin is mitogenic for guinea pig lymphocytes. Scand J Immunol 24: 575-581, 1986. (Pubitemid 17189278)
180. Maines MD. New developments in the regulation of heme metabolism and their implications. Crit Rev Toxicol 12: 241-314, 1984.
181. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2: 2557-2568, 1988.
182. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997. (Pubitemid 27238886)
183. Maines MD and Kappas A. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc Natl Acad Sci USA 71: 4293-4297, 1974.
184. Maines MD, Trakshel GM, and Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 261: 411-419, 1986. (Pubitemid 16103962)
185. Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C, and Levin M. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin Infect Dis 40: 538-545, 2005. (Pubitemid 40270223)
186. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222: 649-655, 1984. (Pubitemid 14007832)
187. Masella R, Di Benedetto R, Vari R, Filesi C, and Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 16: 577-586, 2005. (Pubitemid 41338369)
188. Mattu RK, Trevelyan J, Needham EW, Khan M, Adiseshiah MA, Richter D, Murray RG, and Betteridge DJ. Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes. Diabetologia 45: 905-913, 2002.
189. May K, Rosenlof L, Olsson MG, Centlow M, Morgelin M, Larsson I, Cederlund M, Rutardottir S, Siegmund W, Schneider H, Akerstrom B, and Hansson SR. Perfusion of human placenta with hemoglobin introduces preeclampsialike injuries that are prevented by alpha(1)-microglobulin. Placenta 32: 323-332, 2011.
190. May K, Grube M, Mallhotra I, Long CA, Singh S, Mandilaya K, Siegmund W, Fusch C, Schneider H, and King CL. Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model. PloS One 4: e7986, 2009.
191. McCord JM and Fridovich I. Superoxide dismutase. an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055, 1969.
192. McCoubrey WK, Jr., and Maines MD. Domains of rat heme oxygenase-2: the amino terminus and histidine 151 are required for heme oxidation. Arch Biochem Biophys 302: 402-408, 1993. (Pubitemid 23212689)
193. McCoubrey WK, Jr., and Maines MD. The structure, organization and differential expression of the gene encoding rat heme oxygenase-2. Gene 139: 155-161, 1994. (Pubitemid 24078716)
194. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, and Levy AP. Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98: 3693-3698, 2001.
195. Mendez E, Fernandez-Luna JL, Grubb A, and Leyva-Cobian F. Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis. Proc Natl Acad Sci USA 83: 1472-1475, 1986. (Pubitemid 16016151)
196. Miller YI and Shaklai N. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta 1454: 153-164, 1999. (Pubitemid 29322022)
197. Motterlini R. Carbon monoxide-releasing molecules (CORMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans 35: 1142-1146, 2007. (Pubitemid 350214248)
198. Murphy BP, Inder TE, Rooks V, Taylor GA, Anderson NJ, Mogridge N, Horwood LJ, and Volpe JJ. Posthaemorrhagic ventricular dilatation in the premature infant: natural history and predictors of outcome. Arch Dis Child Fetal Neonatal Ed 87: F37-F41, 2002. (Pubitemid 34753797)
199. Mustacich D and Powis G. Thioredoxin reductase. Biochem J 346 Pt 1: 1-8, 2000. (Pubitemid 30113812)
200. Nakata J, Nakahari A, Kato Y, Yamachi N, Sato N, Yonezawa T, Takahashi C, Chikazawa S, Hori Y, Kanai K, Ito N, Higuchi S, and Hoshi F. Molecular cloning and expression analysis of feline alpha1-microglobulin. Vet Immunol Immunopathol 139: 79-82, 2011.
201. Natanson C, Kern SJ, Lurie P, Banks SM, and Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 299: 2304-2312, 2008. (Pubitemid 351724397)
202. Nauseef WM, Metcalf JA, and Root RK. Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood 61: 483-492, 1983. (Pubitemid 13148147)
203. Nelzen O, Bergqvist D, and Lindhagen A. Leg ulcer etiology-a cross sectional population study. J Vasc Surg 14: 557-564, 1991.
204. Nelzen O, Bergqvist D, Lindhagen A, and Hallbook T. Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. J Epidemiol Community Health 45: 184-187, 1991.
205. Neumann CA, Cao J, and Manevich Y. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle 8: 4072-4078, 2009.
206. Nielsen MJ and Moestrup SK. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 114: 764-771, 2009.
207. Nielsen MJ, Moller HJ, and Moestrup SK. Hemoglobin and heme scavenger receptors. Antioxid Redox Signal 12: 261-273, 2010.
208. Nielsen MJ, Petersen SV, Jacobsen C, Thirup S, Enghild JJ, Graversen JH, and Moestrup SK. A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J Biol Chem 282: 1072-1079, 2007. (Pubitemid 47076555)
209. Noguchi M, Yoshida T, and Kikuchi G. Identification of the product of heme degradation catalyzed by the heme oxygenase system as biliverdin IX alpha by reversed-phase high-performance liquid chromatography. J Biochem 91: 1479-1483, 1982. (Pubitemid 12010320)
210. Nordberg J, Allhorn M, Winqvist I, Akerström B, and Olsson ML. Quantitative and qualitative evaluation of plasma and urine a1-microglobulin in healthy donors and patients with different haemolytic disorders and haemochromatosis. Clin Chim Acta 386: 31-37, 2007. (Pubitemid 47417959)
211. Nordberg J and Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31: 1287-1312, 2001. (Pubitemid 33145299)
212. Odum L and Nielsen HW. Human protein HC (alpha 1-microglobulin) and inter-alpha-trypsin inhibitor in connective tissue. Histochem J 26: 799-803, 1994. (Pubitemid 24325615)
213. Odum L and Nielsen HW. Bikunin and alpha 1-microglobulin in human zona pellucida and connective tissue. Histochem J 29: 199-203, 1997. (Pubitemid 27223404)
214. Ohsawa I, Uehara Y, Hashimoto S, Endo M, Fujita T, and Ohi H. Autoimmune hemolytic anemia occurred prior to evident nephropathy in a patient with chronic hepatitis C virus infection: case report. BMC Neprol 29: 31-37, 2003.
215. Okuda S, Nishiyama N, Saito H, and Katsuki H. Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci USA 93: 12553-12558, 1996. (Pubitemid 26367182)
216. Olsson MG, Allhorn M, Larsson J, Cederlund M, Lundqvist K, Schmidtchen A, Sorensen OE, Mörgelin M, and Akerstro ̈m B. Up-regulation of A1M/a1-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage. PLoS One 6: e27505, 2011.
217. Olsson MG, Allhorn M, Olofsson T, and Akerström B. Upregulation of a1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and blood cell lines. Free Radic Biol Med 42: 842-851, 2007. (Pubitemid 46274169)
218. Olsson MG, Centlow M, Rutardóttir S, Stenfors I, Larsson J, Hosseini-Maaf B, Olsson ML, Hansson SR, and Akerström B. Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger a1-microglobulin in preeclampsia. Free Radic Biol Med 48: 284-291, 2010.
219. Olsson MG, Nilsson EJ, Rutardottir S, Paczesny J, Pallon J, and Akerström B. Bystander cell death and stress response is inhibited by the radical scavenger a1-microglobulin in irradiated cell cultures. Radiat Res 174: 590-600, 2010.
220. Olsson MG, Olofsson T, Tapper H, and Akerström B. The lipocalin a1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species. Free Radic Res 42: 725-736, 2008.
221. Otterbein LE, Mantell LL, and Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 276: L688-L694, 1999. (Pubitemid 29211371)
222. Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, and Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 22: 18-35, 2003. (Pubitemid 36164454)
223. Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 37: 291-293, 1939.
224. Paoli M, Anderson BF, Baker HM, Morgan WT, Smith A, and Baker EN. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two betapropeller domains. Nat Struct Biol 6: 926-931, 1999. (Pubitemid 29463305)
225. Park J, Cha DH, Lee SJ, Kim YN, Kim YH, and Kim KP. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp Mol Med 43: 427-435, 2011.
226. Pawlak D, Pawlak K, Malyszko J, Mysliwiec M, and Buczko W. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol 33: 399-404, 2001. (Pubitemid 34575400)
227. Petz LD and Garatty G. Immune Hemolytic Anemias, 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.
228. Piantadosi CA. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med 45: 562-569, 2008.
229. Poli G, Leonarduzzi G, Biasi F, and Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem 11: 1163-1182, 2004. (Pubitemid 38585060)
230. Polticelli F, Bocedi A, Minervini G, and Ascenzi P. Human haptoglobin structure and function-a molecular modelling study. FEBS J 275: 5648-5656, 2008.
231. Polyzos NP, Mauri D, Tsappi M, Tzioras S, Kamposioras K, Cortinovis I, and Casazza G. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 62: 202-206, 2007. (Pubitemid 46294789)
232. Quiocho FA. Atomic structures of periplasmic binding proteins and the high-affinity active transport systems in bacteria. Philos Trans R Soc Lond B Biol Sci 326: 341-351; discussion 351-352, 1990.
233. Rajagopal A, Rao AU, Amigo J, Tian M, Upadhyay SK, Hall C, Uhm S, Mathew MK, Fleming MD, Paw BH, Krause M, and Hamza I. Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature 453: 1127-1131, 2008. (Pubitemid 351871730)
234. Raju VS, McCoubrey WK, Jr., and Maines MD. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim Biophys Acta 1351: 89-104, 1997. (Pubitemid 27117471)
235. Reeder BJ. The redox activity of hemoglobins: from physiologic functions to pathologic mechanisms. Antioxid Redox Signal 13: 1087-1123, 2010.
236. Reeder BJ, Cutruzzala F, Bigotti MG, Hider RC, and Wilson MT. Tyrosin as a redox-active center in electron transfer to ferryl heme in globins. Free Radic Biol Med 44: 274-283, 2008.
237. Reeder BJ, Grey M, Silaghi-Dumitrescu RL, Svistunenko DA, Bulow L, Cooper CE, and Wilson MT. Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes. J Biol Chem 283: 30780-30787, 2008.
238. Regan RF and Panter SS. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett 153: 219-222, 1993. (Pubitemid 23147074)
239. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO, 3rd, Schechter AN, and Gladwin MT. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8: 1383-1389, 2002. (Pubitemid 36019423)
240. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16: 5-15, 1998. (Pubitemid 28285299)
241. Roberts JM and Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 357: 53-56, 2001. (Pubitemid 32056505)
242. Roberts JM and Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354: 788-789, 1999. (Pubitemid 29415578)
243. Roberts JM and Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 30 Suppl A: S32-S37, 2009.
244. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, Thorp JM, Jr., Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Smith WJ, Saade G, Sorokin Y, and Anderson GB. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 362: 1282-1291, 2010.
245. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, and McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204, 1989. (Pubitemid 20007682)
246. Roche CJ, Malashkevich V, Balazs TC, Dantsker D, Chen Q, Moreira J, Almo SC, Friedman JM, and Hirsch RE. Structural and functional studies indicating altered redox properties of hemoglobin E: implications for production of bioactive nitric oxide. J Biol Chem 286: 23452-23466, 2011.
247. Rosenfeld M and Surgenor DM. Methemalbumin, interaction between human serum albumin and ferriprotoporphyrin IX. J Biol Chem 183: 663-677, 1950.
248. Rother RP, Bell L, Hillmen P, and Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293: 1653-1662, 2005. (Pubitemid 40471796)
249. Rouet P, Raguenez G, Ruminy P, and Salier JP. An array of binding sites for hepatocyte nuclear factor 4 of high and low affinities modulates the liver-specific enhancer for the human alpha1-microglobulin/bikunin precursor. Biochem J 334 (Pt 3): 577-584, 1998. (Pubitemid 28457205)
250. Rouet P, Raguenez G, Tronche F, Yaniv M, N'Guyen C, and Salier JP. A potent enhancer made of clustered liver-specific elements in the transcription control sequences of human alpha 1-microglobulin/bikunin gene. J Biol Chem 267: 20765-20773, 1992.
251. Ryter SW and Choi AM. Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal 7: 80-91, 2005. (Pubitemid 40187927)
252. Sakai H, Takeoka S, and Kobayashi K. Gas bioengineering using hemoglobin-vesicles for versatile clinical applications. Curr Pharm Des 17: 2352-2359, 2011.
253. Sala A, Campagnoli M, Perani E, Romano A, Labo S, Monzani E, Minchiotti L, and Galliano M. Human alpha-1-microglobulin is covalently bound to kynurenine-derived chromophores. J Biol Chem 279: 51033-51041, 2004. (Pubitemid 40017844)
254. Salier JP, Rouet P, Raguenez G, and Daveau M. The interalpha-inhibitor family: from structure to regulation. Biochem J 315 (Pt 1): 1-9, 1996.
255. Salier JP, Simon D, Rouet P, Raguenez G, Muscatelli F, Gebhard W, Guenet JL, and Mattei MG. Homologous chromosomal locations of the four genes for inter-alphainhibitor and pre-alpha-inhibitor family in human and mouse: assignment of the ancestral gene for the lipocalin superfamily. Genomics 14: 83-88, 1992.
256. Salier JP, Verga V, Doly J, Diarra-Mehrpour M, and Erickson RP. The genes for the inter-alpha-inhibitor family share a homologous organization in human and mouse. Mamm Genome 2: 233-239, 1992.
257. Sano S, Sano T, Morishima I, Shiro Y, and Maeda Y. On the mechanism of the chemical and enzymic oxygenations of alpha-oxyprotohemin IX to Fe.biliverdin IX alpha. Proc Natl Acad Sci USA 83: 531-535, 1986.
258. Santin M and Cannas M. Collagen-bound alpha1-microglobulin in normal and healed tissues and its effect on immunocompetent cells. Scand J Immunol 50: 289-295, 1999. (Pubitemid 29399902)
259. Sazama K. Transfusion errors: scope of the problem, consequences, and solutions. Curr Hematol Rep 2: 518-521, 2003.
260. Schaer CA, Schoedon G, Imhof A, Kurrer MO, and Schaer DJ. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res 99: 943-950, 2006. (Pubitemid 44657797)
261. Schmitt TH, Frezzatti WA, Jr., and Schreier S. Hemininduced lipid membrane disorder and increased permeability: a molecular model for the mechanism of cell lysis. Arch Biochem Biophys 307: 96-103, 1993. (Pubitemid 23333980)
262. Schneider H and Huch A. Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib Gynecol Obstet 13: 40-47, 1985. (Pubitemid 15120212)
263. Schrader M and Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta 1763: 1755-1766, 2006. (Pubitemid 44880480)
264. Schroeder BM. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. Am Fam Physician 66: 330-331, 2002. (Pubitemid 34810086)
265. Sears DA. Disposal of plasma heme in normal man and patients with intravascular hemolysis. J Clin Invest 49: 5-14, 1970.
266. Seidah NG, Mayer G, Zaid A, Rousselet E, Nassoury N, Poirier S, Essalmani R, and Prat A. The activation and physiological functions of the proprotein convertases. Int J Biochem Cell Biol 40: 1111-1125, 2008.
267. Seon BK and Pressman D. Unique human glycoprotein, alpha1- microglycoprotein: isolation from the urine of a cancer patient and its characterization. Biochemistry 17: 2815-2821, 1978. (Pubitemid 8385283)
268. Seve P, Philippe P, Dufour JF, Broussolle C, and Michel M. Autoimmune hemolytic anemia: classification and therapeutic approaches. Expert Rev Hematol 1: 189-204, 2008.
269. Shatwell KP and Segal AW. NADPH oxidase. Int J Biochem Cell Biol 28: 1191-1195, 1996. (Pubitemid 27033135)
270. Shennan AH, Poston L, Chappell LC, and Seed PT. Prevention of pre-eclampsia. Lancet 357: 1534, 2001.
271. Shigetomi H, Onogi A, Kajiwara H, Yoshida S, Furukawa N, Haruta S, Tanase Y, Kanayama S, Noguchi T, Yamada Y, Oi H, and Kobayashi H. Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain. Inflamm Res 59: 679-687, 2010.
272. Shiva S, Moellering D, Ramachandran A, Levonen AL, Landar A, Venkatraman A, Ceaser E, Ulasova E, Crawford JH, Brookes PS, Patel RP, and Darley-Usmar VM. Redox signalling: from nitric oxide to oxidized lipids. Biochem Soc Symp 71: 107-120, 2004. (Pubitemid 41185480)
273. Smith TF, Gaitatzes C, Saxena K, and Neer EJ. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 24: 181-185, 1999. (Pubitemid 29348450)
274. Springer TA. Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci USA 94: 65-72, 1997.
275. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, Chapman CE, Davison K, Gerrard R, Gray A, Knowles S, Love EM, Milkins C, McClelland DB, Norfolk DR, Soldan K, Taylor C, Revill J, Williamson LM, and Cohen H. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 20: 273-282, 2006. (Pubitemid 44428107)
276. Steinberg MH. (Ed). Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management: Cambridge University Press, Cambridge, 2001.
277. Stevens JM. Gynaecology from ancient Egypt: the papyrus Kahun: a translation of the oldest treatise on gynaecology that has survived from the ancient world. Med J Aust 2: 949-952, 1975.
278. Stillman IE and Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 18: 2281-2284, 2007. (Pubitemid 47203843)
279. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987. (Pubitemid 17049750)
280. Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S, Willner J, and Olsen S. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 110: 831-836, 2003. (Pubitemid 37159268)
281. Sundaram M, Sivaprasadarao A, Aalten DM, and Findlay JB. Expression, characterization and engineered specificity of rat epididymal retinoic acid-binding protein. Biochem J 334 (Pt 1): 155-160, 1998. (Pubitemid 28420984)
282. Sutton HC and Winterbourn CC. On the participation of higher oxidation states of iron and copper in Fenton reactions. Free Radic Biol Med 6: 53-60, 1989. (Pubitemid 19032731)
283. Takagi T, Takagi K, and Kawai T. Complete amino acid sequence of human alpha 1-microglobulin. Biochem Biophys Res Commun 98: 997-1001, 1981. (Pubitemid 11110394)
284. Talosi G, Endreffy E, Turi S, and Nemeth, I. Molecular and Genetic Aspects of Preeclampsia: State of the Art. Mol Genet Metab 71: 565-572, 2000. (Pubitemid 32039343)
285. Tam SC and Wong JT. Impairment of renal function by stroma-free hemoglobin in rats. J Lab Clin Med 111: 189-193, 1988. (Pubitemid 18074322)
286. Tavakkol A. Molecular cloning of porcine alpha 1-microglobulin/HI-30 reveals developmental and tissue-specific expression of two variant messenger ribonucleic acids. Biochim Biophys Acta 1088: 47-56, 1991.
287. Tavazzi D, Taher A, and Cappellini MD. Red blood cell enzyme disorders: an overview. Pediatr Ann 37: 303-310, 2008. (Pubitemid 351847502)
288. Tejler L, Eriksson S, Grubb A, and Astedt B. Production of protein HC by human fetal liver explants. Biochim Biophys Acta 542: 506-514, 1978. (Pubitemid 9001091)
289. Tejler L and Grubb AO. A complex-forming glycoprotein heterogeneous in charge and present in human plasma, urine, and cerebrospinal fluid. Biochim Biophys Acta 439: 82-94, 1976.
290. Tenhunen R, Marver HS, and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 61: 748-755, 1968.
291. Tenhunen R, Marver HS, and Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 244: 6388-6394, 1969.
292. ter Haar E, Musacchio A, Harrison SC, and Kirchhausen T. Atomic structure of clathrin: a beta propeller terminal domain joins an alpha zigzag linker. Cell 95: 563-573, 1998. (Pubitemid 28533312)
293. Thornton JG and Macdonald AM. Twin mothers, pregnancy hypertension and pre-eclampsia. Br J Obstet Gynaecol 106: 570-575, 1999. (Pubitemid 29245589)
294. Thuveson M and Fries E. Intracellular proteolytic processing of the heavy chain of rat pre-alpha-inhibitor. The COOH-terminal propeptide is required for coupling to bikunin. J Biol Chem 274: 6741-6746, 1999. (Pubitemid 29111096)
295. Tolosano E and Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol 21: 297-306, 2002. (Pubitemid 34594543)
296. Trakshel GM, Kutty RK, and Maines MD. Purification and characterization of the major constitutive form of testicular heme oxygenase. The noninducible isoform. J Biol Chem 261: 11131-11137, 1986. (Pubitemid 17216715)
297. Treloar SA, Cooper DW, Brennecke SP, Grehan MM, and Martin NG. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstet Gynecol 184: 374-381, 2001. (Pubitemid 32206987)
298. Tripette J, Alexy T, Hardy-Dessources MD, Mougenel D, Beltan E, Chalabi T, Chout R, Etienne-Julan M, Hue O, Meiselman HJ, and Connes P. Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease. Haematologica 94: 1060-1065, 2009.
299. Tsemakhovich VA, Bamm VV, Shaklai M, and Shaklai N. Vascular damage by unstable hemoglobins: the role of heme-depleted globin. Arch Biochem Biophys 436: 307-315, 2005. (Pubitemid 40576270)
300. Vandegriff KD, Young MA, Lohman J, Bellelli A, Samaja M, Malavalli A, and Winslow RM. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol 154: 1649-1661, 2008.
301. Vanlair CF and Masius JR. De la microcythemie. Bull Acad Med Belg 3e Ser 5: 515-613, 1871.
302. Vaughn MW, Huang KT, Kuo L, and Liao JC. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem 275: 2342-2348, 2000. (Pubitemid 30081991)
303. Vazquez S, Garner B, Sheil MM, and Truscott RJ. Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions. Free Radic Res 32: 11-23, 2000. (Pubitemid 30010604)
304. Vichinsky E. Hemoglobin E syndromes. Hematol Am Soc Hematol Educ Program 79-83, 2007.
305. Vile GF, Basu-Modak S, Waltner C, and Tyrrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci USA 91: 2607-2610, 1994. (Pubitemid 24139396)
306. Villoutreix BO, Akerström B, and Lindqvist A. Structural model of human a1-microglobulin: proposed scheme for the interaction with the Gla domain of anticoagulant protein C. Blood Coagul Fibrinolysis 11: 261-275, 2000. (Pubitemid 30331807)
307. Vincent C, Bouic P, and Revillard JP. Characterization of rat alpha 1 microglobulin. Biochem Biophys Res Commun 116: 180-188, 1983.
308. Vohr BR, Wright LL, Dusick AM, Mele L, Verter J, Steichen JJ, Simon NP, Wilson DC, Broyles S, Bauer CR, Delaney-Black V, Yolton KA, Fleisher BE, Papile LA, and Kaplan MD. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 105: 1216-1226, 2000. (Pubitemid 30346889)
309. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 7: 56-64, 2001. (Pubitemid 32206303)
310. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, and Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811, 2001.
311. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, and Harmatz P. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 135: 254-263, 2006. (Pubitemid 44401624)
312. Weisiger RA and Fridovich I. Superoxide dismutase. Organelle specificity. J Biol Chem 248: 3582-3592, 1973.
313. Wester L, Fast J, Labuda T, Cedervall T, Wingardh K, Olofsson T, and Akerström B. Carbohydrate groups of a1-microglobulin are important for secretion and tissue localization but not for immunological properties. Glycobiology 10: 891-900, 2000.
314. Wester L, Michaelsson E, Holmdahl R, Olofsson T, and Akerström B. Receptor for a1-microglobulin on T lymphocytes: inhibition of antigen-induced interleukin-2 production. Scand J Immunol 48: 1-7, 1998. (Pubitemid 28329146)
315. Whitelaw A, Jary S, Kmita G, Wroblewska J, Musialik-Swietlinska E, Mandera M, Hunt L, Carter M, and Pople I. Randomized trial of drainage, irrigation and fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation: developmental outcome at 2 years. Pediatrics 125: e852-e858, 2010.
316. Whitelaw A, Thoresen M, and Pople I. Posthaemorrhagic ventricular dilatation. Arch Dis Child Fetal Neonatal Ed 86: F72-F74, 2002. (Pubitemid 34250880)
317. Wicher KB and Fries E. Haptoglobin, a hemoglobin-binding plasma protein, is present in bony fish and mammals but not in frog and chicken. Proc Natl Acad Sci USA 103: 4168-4173, 2006.
318. Wicher KB and Fries E. Evolutionary aspects of hemoglobin scavengers. Antioxid Redox Signal 12: 249-259, 2010.
319. Wilkinson LS, Bunker C, Edwards JC, Scurr JH, and Smith PD. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 17: 669-675, 1993. (Pubitemid 23124944)
320. Wilks A. Heme oxygenase: evolution, structure, and mechanism. Antioxid Redox Signal 4: 603-614, 2002. (Pubitemid 35001444)
321. Williams MS and Kwon J. T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic Biol Med 37: 1144-1151, 2004. (Pubitemid 39296739)
322. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, and Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 115: 997-1003, 2005.
323. Wu Y, Zhao XD, Zhuang Z, Xue YJ, Cheng HL, Yin HX, and Shi JX. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobininduced Toll-like receptor 4 expression in vascular smooth muscle cells. Brain Res 1322: 102-108, 2010.
324. Yoshida T, Takahashi S, and Kikuchi G. Partial purification and reconstitution of the heme oxygenase system from pig spleen microsomes. J Biochem 75: 1187-1191, 1974.
325. Yu B, Bloch KD, and Zapol WM. Hemoglobin-based red blood cell substitutes and nitric oxide. Trends Cardiovasc Med 19: 103-107, 2009.
326. Zamboni P, Izzo M, Tognazzo S, Carandina S, De Palma M, Catozzi L, Caggiati A, Scapoli G, and Gemmati D. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med 40: 1869-1873, 2006.
327. Zamboni P, Scapoli G, Lanzara V, Izzo M, Fortini P, Legnaro R, Palazzo A, Tognazzo S, and Gemmati D. Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg 31: 644-649; discussion 649, 2005. (Pubitemid 43093415)
328. Zamboni P, Tognazzo S, Izzo M, Pancaldi F, Scapoli GL, Liboni A, and Gemmati D. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg 42: 309-314, 2005. (Pubitemid 41139239)
329. Zhang N and Palmer AF. Polymerization of human hemoglobin using the crosslinker 1,11-bis(maleimido)-triethylene glycol for use as an oxygen carrier. Biotechnol Prog 26: 1481-1485, 2010.
330. Zhou H, Beevers CS, and Huang S. The targets of curcumin. Curr Drug Targets 12: 332-347, 2011.
331. Zhou ML, Shi JX, Hang CH, Zhang FF, Gao J, and Yin HX. Expression of Toll-like receptor 4 in the brain in a rabbit experimental subarachnoid haemorrhage model. Inflamm Res 56: 93-97, 2007. (Pubitemid 46570791)
332. Zhou Z and Kang YJ. Cellular and subcellular localization of catalase in the heart of transgenic mice. J Histochem Cytochem 48: 585-594, 2000. (Pubitemid 30233182)
333. Akerström B. Tissue distribution of guinea pig a1-microglobulin. Cell Mol Biol 29: 489-495, 1983.
334. Akerström B. Immunological analysis of a1-microglobulin in different mammalian and chicken serum. a1-Microglobulin is 5-8 kilodaltons larger in primates. J Biol Chem 260: 4839-4844, 1985.
335. Akerström B and Berggard I. Guinea-pig alpha 1 microglobulin. Isolation and properties in comparison with human a1-microglobulin. Eur J Biochem 101: 215-223, 1979.
336. Akerström B, Bratt T, and Enghild JJ. Formation of the a1-microglobulin chromophore in mammalian and insect cells: a novel post-translational mechanism? FEBS Lett 362: 50-54, 1995.
337. Akerström B, Flower DR, and Salier JP. Lipocalins: unity in diversity. Biochim Biophys Acta 1482: 1-8, 2000.
338. Akerström B and Lögdberg L. An intriguing member of the lipocalin protein family: a1-microglobulin. Trends Biochem Sci 15: 240-243, 1990.
339. Akerström B and Lögdberg L. a1-microglobulin. In: In: Lipocalins, edited by Akerström B, Borregaard N, Flower DR, and Salier J-P. Georgetown, TX: Landes Bioscience, 2006, pp. 110-120.
340. Akerström B, Lögdberg L, Babiker-Mohamed H, Lohmander S, and Rask L. Structural relationship between a1-microglobulin from man, guinea-pig, rat and rabbit. Eur J Biochem 170: 143-148, 1987.
341. Akerström B, Maghzal GJ, Winterbourn CC, and Kettle AJ. The lipocalin a1-microglobulin has radical scavenging activity. J Biol Chem 282: 31493-31503, 2007. (Pubitemid 350063946)